Tag: Roots Analysis
The stem cell therapy market
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism.
Over 85 firms are involved in providing fragment-based drug discovery-related services; of these, around 40 players claim to offer both libraries and technologies
Accordingto experts in this field, fragment-based drug discovery solutions havefacilitated the identification of viable pharmacological leads againstotherwise hard to target biomolecules. In fact, many service provider companiesare offering fragment libra...
The fragment-based drug discovery market is projected to grow at an annualized
Roots Analysis has done a detailed study on Fragment-based Drug DiscoveryMarket: Library and Service Providers, 2020-2030”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis
Screening small molecule fragments hasmade it possible to identify pharmacological leads against otherwise hard totarget hotspots on biomolecules, such as allosteric sites, rendering thisapproach a valuable alternative method of drug discovery
Growing at an annualized rate of 10%, the fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, claims Roots Analysis
Traditional drug discovery is associated with exorbitantinvestments, prolonged lead evolution timelines and high attrition rates; thefragment-based approach is a versatile technique, enabling researchers tomitigate a number of existing challenges
The oligonucleotide synthesis, modification and purification services market is projected to grow at an annualized rate of ~10%
More than 80companies currently claim to offer manufacturing related services, at differentscales of operations, for a variety of oligonucleotide-based products
The oligonucleotide synthesis, modification and purification services market is estimated to be worth USD 5.8 billion in 2030, predicts Roots Analysis
The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs
The oligonucleotide synthesis, modification and purification services market is projected to be worth USD 5.8 billion, growing at a CAGR of 10%, claims Roots Analysis
The rapidly growing demand for oligonucleotides,coupled to complex manufacturing procedures and high capital investmentsrequired for setting up manufacturing facilities, has generated a range of newopportunities for custom manufacturers
Patient Recruitment and Retention Services, 2019-2030’
A detailed assessment of the current market landscape, including information on drug developer(s),
The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030
Roots Analysis has done a detailedstudy PatientRecruitment and Retention Services Marker, 2019-2030.”
The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis
A steadily increasingdemand for participants in clinical research studies, coupled to thecomplexities associated with patient enrolment, have prompted drug / therapydevelopers to outsource this process to specialty service providers
Oligonucleotide Synthesis, Modification and Purification Services Market
A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications. It features information on the year of establishment
80 companies currently claim to offer manufacturing related services, at different scales of operations, for a variety of oligonucleotide-based products, claims Roots Analysis
Severalbig pharma companies are known to outsource more than half of their clinical-stageoligonucleotide manufacturing operations.
The market opportunity for AR / VR based healthcare digital marketing service providers is likely to grow at a CAGR of 26% - RA
Over time, manypharma companies have begun incorporating augmented reality (AR) and virtualreality (VR) features, in order to offer an experiential and interactivedimension to their educational / marketing content
The opportunity for AR / VR based digital marketing service providers in healthcare sector is projected to be worth USD 3 billion by 2030 at significant CAGR of 26% claims, Roots Analysis
Given the presentscenario, many stakeholders are adopting such advanced marketing strategies todrive better consumer engagement through the use of immersive and interactivetechnologies
